Alger Jason has filed 19 insider transactions across 1 company since February 2024.
Most recent transaction: a tax payment of 26970 shares of Health Catalyst, Inc. ($HCAT) on March 02, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 26970 | $1.66 | 741,644.0000 | 70,730,884 | 3.51% | 0.04% |
| Feb. 26, 2026 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 7522 | $1.75 | 768,614.0000 | 70,730,884 | 0.97% | 0.01% |
| Feb. 25, 2026 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | A | Common Stock | 22222 | $0.00 | 776,136.0000 | 70,730,884 | 2.95% | 0.03% |
| Feb. 25, 2026 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | A | Common Stock | 507500 | $0.00 | 753,914.0000 | 70,730,884 | 205.95% | 0.72% |
| Dec. 1, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 20619 | $2.90 | 246,414.0000 | 70,730,884 | 7.72% | 0.03% |
| Sept. 2, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 2613 | $3.36 | 267,033.0000 | 70,210,651 | 0.97% | 0.00% |
| June 2, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 2712 | $3.63 | 269,646.0000 | 70,210,651 | 1.00% | 0.00% |
| March 3, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 7304 | $4.58 | 272,358.0000 | 70,210,651 | 2.61% | 0.01% |
| Feb. 20, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | A | Common Stock | 181000 | $0.00 | 267,712.0000 | 70,210,651 | 208.74% | 0.26% |
| Feb. 20, 2025 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | A | Common Stock | 11950 | $0.00 | 279,662.0000 | 70,210,651 | 4.46% | 0.02% |
| Dec. 6, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | S | Common Stock | 19599 | $8.32 | 86,712.0000 | 0 | 18.44% | 0.00% |
| Dec. 1, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 7795 | $8.97 | 106,311.0000 | 0 | 6.83% | 0.00% |
| Sept. 6, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | S | Common Stock | 2899 | $7.39 | 114,106.0000 | 0 | 2.48% | 0.00% |
| Sept. 3, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 1165 | $7.27 | 117,005.0000 | 0 | 0.99% | 0.00% |
| June 12, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | S | Common Stock | 2823 | $6.83 | 118,170.0000 | 0 | 2.33% | 0.00% |
| June 3, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 1238 | $6.53 | 120,993.0000 | 0 | 1.01% | 0.00% |
| March 1, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | A | Common Stock | 70000 | $0.00 | 122,231.0000 | 0 | 134.02% | 0.00% |
| March 1, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Financial Officer | F | Common Stock | 2474 | $8.05 | 52,231.0000 | 0 | 4.52% | 0.00% |
| Feb. 20, 2024 | Health Catalyst, Inc. | $HCAT | Alger Jason | Chief Accounting Officer | A | Common Stock | 2778 | $0.00 | 54,705.0000 | 0 | 5.35% | 0.00% |